About CorVista
CorVista is a company based in Toronto (Canada) founded in 2012. CorVista has raised $203.53 million across 16 funding rounds from investors including MedVenture Partners. The company has 5 employees as of December 31, 2024. CorVista offers products and services including CorVista System. CorVista operates in a competitive market with competitors including Cardiotrack, Powerful Medical, Larkai Healthcare, Shenzhen Ruixin Intelligent Medical Technology and Anumana, among others.
- Headquarter Toronto, Canada
- Employees 5 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name A4l(Us) Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$203.53 M (USD)
in 16 rounds
-
Latest Funding Round
$550 K (USD), Series C
Oct 06, 2025
- Investors
-
Employee Count
5
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CorVista
CorVista offers a comprehensive portfolio of products and services, including CorVista System.
Non-invasive machine learning system for detecting cardiac diseases at point of care.
People of CorVista
Unlock access to complete
Unlock access to complete
Funding Insights of CorVista
CorVista has successfully raised a total of $203.53M across 16 strategic funding rounds. The most recent funding activity was a Series C round of $550 thousand completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CorVista
CorVista has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MedVenture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
MedVenture Partners is focused on medical device venture investments.
|
Locked | Locked | Locked |
Investor details for CorVista
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CorVista
Investment portfolio details for CorVista
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CorVista
Detailed financials for CorVista
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Corvista Comparisons
Peer comparison for CorVista
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CorVista
CorVista operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardiotrack, Powerful Medical, Larkai Healthcare, Shenzhen Ruixin Intelligent Medical Technology and Anumana, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based EGC data capture and analysis platform
|
|
| Locked | Locked | Locked |
AI-powered devices for cardiovascular diagnostics and management are provided.
|
|
| Locked | Locked | Locked |
AI-powered diagnostic and monitoring solutions for cardiopulmonary anomalies are provided.
|
|
| Locked | Locked | Locked |
AI-based medical imaging tools for cardiac disease diagnosis are provided.
|
|
| Locked | Locked | Locked |
AI-based ECG analysis and cardiology diagnosis tools are developed.
|
Detailed competitors of CorVista
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Corvista
Complete news archive for CorVista
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CorVista
CorVista was founded in 2012 and raised its 1st funding round 3 years after it was founded.
CorVista is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Adrian Lam is the current CEO of CorVista.
CorVista is a funded company, having raised a total of $203.53M across 16 funding rounds to date.
As of Dec 31, 2024, the latest employee count at CorVista is 5.
CorVista was founded in 2012 in Toronto, Canada, and operates within the healthcare sector. An AI-based diagnostic tool named CorVista is offered to healthcare professionals for detecting cardiovascular conditions. Patient data is analyzed by the software to identify diseases including pulmonary hypertension, heart failure, and coronary artery disease. The companys focus remains on supporting clinical diagnostics through this technology.
CorVista's top competitors include Powerful Medical, Cardiotrack and Keya Medical.
CorVista offers CorVista System.
CorVista has 1 investor. Key investors include MedVenture Partners.